Kelly Benchmark Indexes

Kelly ETFs offers investors the opportunity to capture highly liquid, pure-play exposure to the best-in-class companies identified in each emerging theme or sector. Funds offered include the Kelly Hotel & Lodging Sector ETF (NYSE Arca: HOTL), Kelly Residential & Apartment Real Estate ETF (NYSE Arca: RESI), and the Kelly CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA).

Company Schedule

Tuesday, September 27, 2022 - 2:40 pm to 3:10 pm EDT XDNA ETF: CRISPR Curing Disease and Upcoming Catalysts by Kevin Kelly - CEO, Kelly ETFs Focus: ETFs

CRISPR technology has had two watershed moments this summer indicating that it is about change healthcare as we know it. Learn about the upcoming catalysts for publicly traded gene editing companies. At its core, CRISPR is a pair of biological scissors that cut and replace genes in living organisms' cells. It has the potential to disrupt virtually every facet of our lives, from curing genetic diseases, detecting and treating cancers, treating HIV, to even bioengineering new crops and plants to feed the world's growing population.

Wednesday, September 28, 2022 - 10:40 am to 11:10 am EDT How to Capture Real Estate Growth (HOTL and RESI) in an Inflationary and Rising Rate Environment by Kevin Kelly - CEO, Kelly ETFs Focus: ETFs

Not all real estate is created equal— especially in an inflationary environment with rising rates. Kevin Kelly, CEO of Kelly ETFs, will explore how investors can capitalize on high quality real estate in the hotel and residential sectors. Those sectors are benefitting from strong underlying demand coupled with inflationary pricing power. Over the past 25 years, real estate investment trusts (REITs) have emerged as a popular and efficient way for market participants of all stripes to access the real estate asset class. Strong long-term total returns, combined with other key investment characteristics such as liquidity, high dividend yields, potential to increase diversification and to hedge against inflation, have contributed to the appeal of REITs.


For questions please contact our Client Relations Team at 800-970-4355 or 941-955-0323.

Social Updates

Follow us on social media to stay in the loop as more great speakers are added to the schedule!